# Evaluation of the LipiFlow System With a New Activator

> **NCT04500821** · NA · COMPLETED · sponsor: **Johnson & Johnson Surgical Vision, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** Activator LFD-2100

## Key facts

- **NCT ID:** NCT04500821
- **Lead sponsor:** Johnson & Johnson Surgical Vision, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-02
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500821, "Evaluation of the LipiFlow System With a New Activator". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04500821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*